Skip to NavigationSkip to content

News

Childhood obesity has increased ten-fold, China to finally accept overseas trial data and GSK rated worst UK company for governance in new report....
The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from all quarters, given that it...
Thanks to successful negotiation of a managed access agreement, NICE has announced its recommendation of Bristol-Myers Squibb’s Opdivo for inclusion...
Following on from the popularity of our previous free  webinar sessions, Pharmafocus is once...
A vaccine for leprosy, developed by the Infectious Disease Research Institute and with the financial support of the American Leprosy Missions, has...
Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its treatment efficacy against...
In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil)...
NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the treatment of...
MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol drug, anacetrapib.
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection of €170 million to boost...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches